Tag Archives: clinical trials

Galmed Collaboration Announcement

Clinical Accelerator are very pleased to announce collaboration with Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD), on conducting a phase IIB clinical trial for the treatment of patients with overweight or obesity and who are pre diabetic or type II diabetic with … Continue reading

Posted in Clinical Accelerator | Tagged | Leave a comment

The importance of study feasibility

With the finances involved and continuing risk of failure, the importance of careful feasibility assessment and judgment is absolute. To what extent weak – or no – feasibility assessment contributes to clinical trial failures is a challenging question. Feasibility study The … Continue reading

Posted in Feasibility Assessment | Tagged , | Leave a comment